Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-09-25

FDA Approved: FLUVASTATIN SODIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Fluvastatin Sodium (generic) filed by Mylan Pharmaceuticals Inc., enabling continued marketing of the generic pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluvastatin sodium (Fluvastatin sodium)

Snippet

SUPPL AP for FLUVASTATIN SODIUM (FLUVASTATIN)